New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export BNTX’s income statement to Excel — free account
BioNTech SE Sponsored ADR
BNTXBioNTech SE Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 9.07% from fiscal 2024.
- Revenue
- −16.4%
- EPS
- n/m
- Free cash flow
- n/m
- Total debt
- +44.4%
Quarter to September 2026, against a year earlier
81.37
0.02
−0.02%
Follow BNTX
Alert me
Revenue to profit Q3 FY2026, quarter to Sep 30, 2026
Of every $100 of revenue, $18.34 was left as profit. What is an income statement?
| Revenue | 1.5 | 100.0% |
|---|---|---|
| Cost of revenue | −0.1 | −8.0% |
| Gross profit | 1.4 | 92.0% |
| Research & development | −0.9 | −58.0% |
| Selling, general & admin | −0.2 | −13.8% |
| Other operating costs | −0.2 | −10.4% |
| Operating income | 0.1 | 9.7% |
| Other income, net | +0.1 | 7.5% |
| Income tax | 0.0 | −2.9% |
| Other items | +0.1 | 4.0% |
| Net income | 0.3 | 18.3% |
Net margin (right axis)
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Revenue | $983M | $138M | $123M | $1.5B |
| Operating income | −$403M | −$793M | −$1.1B | $144M |
| Net income | −$226M | −$665M | −$994M | $272M |
| Net margin (right axis) | −23.0% | −481.0% | −809.6% | 18.3% |
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Revenue |
1,483.87 | 122.78 | 138.22 | 982.92 |
+8 more quarters Free account |
Revenue Growth |
(16.42%) | (58.53%) | (28.22%) | (22.35%) | |
Cost of Revenue |
118.90 | 112.78 | 83.57 | 377.77 | |
Gross Profit |
1,364.97 | 10.00 | 54.66 | 605.15 | |
R&D Expenses |
861.06 | 640.65 | 651.91 | 589.64 | |
SG&A Expenses |
205.45 | 229.98 | 176.50 | 249.84 | |
Operating Income |
143.87 | (1,102.36) | (792.95) | (403.16) | |
Non-operating Interest Expenses |
9.55 | 9.19 | 13.11 | 5.86 | |
Non-operating Income/Expense |
111.65 | 103.95 | 128.04 | 111.79 | |
| 255.52 | (998.41) | (664.90) | (291.37) | ||
Income Tax Provision |
43.16 | (44.07) | (42.37) | 83.55 | |
Income after Tax |
212.36 | (954.34) | (622.54) | (374.92) | |
Net Income Common |
212.36 | (954.34) | (622.54) | (374.92) | |
EPS (Basic) |
0.85 | (3.77) | (2.46) | (1.46) | |
EPS (Diluted) |
0.84 | (3.77) | (2.46) | (1.46) | |
Shares (Basic, Weighted) |
249.34 | 253.34 | 253.27 | 241.70 | |
Shares (Diluted, Weighted) |
252.75 | 253.34 | 253.27 | 241.70 | |
Gross Margin |
91.99% | 8.14% | 39.54% | 61.57% | |
EBIT Margin |
9.70% | (897.82%) | (573.67%) | (41.02%) | |
EBT margin |
17.22% | (813.16%) | (481.03%) | (29.64%) | |
Net Profit Margin |
14.31% | (777.27%) | (450.38%) | (38.14%) | |
EBITDA |
521.82 | (793.90) | (650.98) | (224.88) | |
EBIT |
143.87 | (1,102.36) | (792.95) | (403.16) | |
Income from Continuous Operations |
212.36 | (954.34) | (622.54) | (374.92) | |
Consolidated Net Income/Loss |
212.36 | (954.34) | (622.54) | (374.92) | |
EPS (Basic, from Continuous Ops) |
0.85 | (3.77) | (2.46) | (1.54) | |
EPS (Diluted, from Cont. Ops) |
0.84 | (3.77) | (2.46) | (1.54) | |
EPS (Basic, Consolidated) |
0.85 | (3.77) | (2.46) | (1.54) | |
EPS (Diluted, Consolidated) |
0.84 | (3.77) | (2.46) | (1.54) | |
Shares (Diluted, Average) |
252.74 | 253.33 | 253.29 | 244.00 | |
EBITDA Margin |
35.17% | (646.59%) | (470.96%) | (22.88%) | |
Operating Cash Flow Margin |
(9.74%) | 12.58% | (356.48%) | 35.07% |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026